elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33393692-D0A71F41-E305-4EC8-B55B-B872EC450946
Q33393692-D0A71F41-E305-4EC8-B55B-B872EC450946
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33393692-D0A71F41-E305-4EC8-B55B-B872EC450946
Direct thrombin inhibitors.
P2860
Q33393692-D0A71F41-E305-4EC8-B55B-B872EC450946
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33393692-D0A71F41-E305-4EC8-B55B-B872EC450946
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d45b7bb869c10142c7960d62f5a4d50185dc1c71
P2860
A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial.